临床试验/NCT00265278

NCT00265278Unknown1 期

Double-Blind, Placebo-Controlled Assessment of Interactions Between Intravenous Methamphetamine and Modafinil

National Institute on Drug Abuse (NIDA)2 个研究点分布在 1 个国家目标入组 16 人开始时间: 2005年3月最近更新: 2017年1月11日

适应症

试验速览

阶段: 1 期
发起方: National Institute on Drug Abuse (NIDA)
入组人数: 16
试验地点: 2
主要终点: Cardiovascular

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral Modafinil.

详细描述

The primary aims of this experiment are to determine if there are significant safety interactions between oral modafinil and intravenous methamphetamine. Safety will be assessed by measuring adverse events and cardiovascular responses of heart rate (HR), blood pressure (BP), and electrocardiogram (ECG) and stroke distance (ICG).

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Treatment
盲法: Double

入排标准

年龄范围: 18 Years 至 45 Years（Adult）
性别: All
接受健康志愿者: 否

入选标准

•normotensive
•good physical and mental health
•body mass index between 18 and 30
•if female, using an acceptable method of contraception and are not pregnant
•able to give voluntary informed consent

排除标准

•Please contact site for further details

结局指标

主要结局

Cardiovascular

Subjective symptoms/Mood Effects

次要结局

未报告次要终点

研究者

发起方

National Institute on Drug Abuse (NIDA)

申办方类型

Nih

研究点 (2)

Loading locations...

相似试验

Unknown

1 期

Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1Amphetamine-Related Disorders

NCT00040040National Institute on Drug Abuse (NIDA)20

Unknown

1 期

Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Amphetamine-Related Disorders

NCT00033072National Institute on Drug Abuse (NIDA)16

Unknown

1 期

Assessment of Interactions Between Methamphetamine and Aripiprazole - 1Amphetamine-Related Disorders

NCT00089440National Institute on Drug Abuse (NIDA)17

Unknown

1 期

A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1Amphetamine-Related Disorders

NCT00267657National Institute on Drug Abuse (NIDA)30

已完成

4 期

Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity DisorderADHD

NCT00223561Utrecht Institute for Pharmaceutical Sciences18